Glycobiology 2936 Harper Street, Berkeley CA 94703
Stefan Hemmerich is an internationally recognized clinical scientist, inflammation biologist and glycobiologist with over seven years of industry experience in clinical research and operations including project management of phase I and II trials conducted under FDA CDER approved INDs in transplantation, inflammation, viral hepatitis, oncology, and cardiovascular disease. He has prepared multiple INDs, non-clinical and clinical protocols, CRFs and study manuals and has over 15 years of experience managing pharmaceutical R&D, grant writing and peer review of grant applications. Dr. Hemmerich is regulatory Affairs Certified (RAC), has a Ph.D. from the Weizmann Institute of Science and conducted post-doctoral research at UCSF. He was Director of Clinical Operations at Therapeutics, was Head of Biology at Thios Pharmaceuticals and held Staff Scientist positions at Roche (Palo Alto, CA) and Syntex. Dr. Hemmerich is author or coauthor of over 40 publications in peer-reviewed scientific and clinical journals.
Glycobiology, Sulfotransferases, Glycosyl-transferases, Glycomics, Adhesion Molecules, Leukocyte Trafficking, Inflammation, Ischemia Reperfusion Injury, Transplantation, Clinical Development, Therapeutic Recombinant Biologics.